摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(S)-2-tert-butyl-4-[(diphenylphosphino)ethyl]oxazoline

中文名称
——
中文别名
——
英文名称
(S)-2-tert-butyl-4-[(diphenylphosphino)ethyl]oxazoline
英文别名
2-[(4S)-2-tert-butyl-4,5-dihydro-1,3-oxazol-4-yl]ethyl-diphenylphosphane
(S)-2-tert-butyl-4-[(diphenylphosphino)ethyl]oxazoline化学式
CAS
——
化学式
C21H26NOP
mdl
——
分子量
339.417
InChiKey
SPCWWZWSLUZFPV-KRWDZBQOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    24
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    21.6
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    (S)-N-tert-butoxycarbonyl-4-ethylenediphenylphosphinoborane-2,2-dimethyloxazolidine 在 盐酸4-二甲氨基吡啶三乙胺 作用下, 以 甲醇1,2-二氯乙烷 为溶剂, 反应 12.34h, 生成 (S)-2-tert-butyl-4-[(diphenylphosphino)ethyl]oxazoline
    参考文献:
    名称:
    新型旋光性膦恶唑啉(JM-Phos)配体:烯丙基化反应的合成及应用。
    摘要:
    介绍了膦恶唑啉系统1的三种不同合成方法。这些方法中的两种是不同的途径,旨在涉及可以转化为几种不同最终产品的高级中间体。第三个是较短的途径,专门设计用于使用最少的官能团保护来促进大规模制备这些系统。总体上,制备了八种不同的膦恶唑啉。这些在几个钯介导的烯丙基化反应中筛选。事实证明,它们对于3-乙酰氧基-1,3-二苯基丙烯的不对称烷基化最有用,而对于更具挑战性的底物(戊烯基衍生物和环己烯基系统)则不太适用/不起作用。复合物[(η3-PhCHCHCHPh)Pd(1a)] [PF6]的X射线晶体学分析得出的结论是,这些系统中不对称诱导的起源可能间接归因于恶唑啉-苯基取代基与环氧基的相互作用。钯和烯丙基苯基取代基。最后,给出了N-酰基恶唑烷酮的甲硅烷基烯丙基化的数据。获得了极好的对映选择性和产率。
    DOI:
    10.1021/jo001333h
点击查看最新优质反应信息

文献信息

  • JM-PHOS Ligands:  Second-Generation Phosphine Oxazolines for Asymmetric Catalysis
    作者:Duen-Ren Hou、Kevin Burgess
    DOI:10.1021/ol991008k
    日期:1999.12.1
    [GRAPHICS]A small library of phosphine oxazoline ligands 2 was prepared and tested in palladium mediated allylation processes (reactions 1 and 2). They were found to be superior to the first generation ligands 1 and as effective as the well known phosphine oxazolines 3.
  • NOVEL LIGANDS FOR CHIRAL CATALYSIS
    申请人:THE TEXAS A&M UNIVERSITY SYSTEM
    公开号:EP1165574A1
    公开(公告)日:2002-01-02
  • US6472533B1
    申请人:——
    公开号:US6472533B1
    公开(公告)日:2002-10-29
  • [EN] NOVEL LIGANDS FOR CHIRAL CATALYSIS<br/>[FR] NOUVEAUX LIGANDS POUR CATALYSE CHIRALE
    申请人:TEXAS A & M UNIV SYS
    公开号:WO2000061589A1
    公开(公告)日:2000-10-19
    Novel phosphine oxazoline ligands of formula (I) wherein m is 1, 2, 3 or 4; n, p, q, r are independently zero or 1 provided that at least one of n, p, q and r is 1; X is O, S, Se, CH2, NH; Y is N, P, As, S; R is H; a straight-chain alkyl group, a branched-chain alkyl group or a cyclo alkyl group optionally substituted by one or more groups independently selected from alkyl, aryl, halo, alkoxy, amine, phosphine and ether groups; an aryl group optionally substituted by one or more groups independently selected from alkyl, aryl, halo, alkoxy, amine, phosphine and ether groups; ferrocenyl; a thioalkyl group; a thioaryl group; or R is derived from a hydrocarbyl group attached to a functional group of an organic compound or a polymer capable of giving rise to the grouping -N-C-X- in the ring structure of (I); R?1 to R13¿ are independently selected from H; a straight-chain alkyl group, a branched-chain alkyl group or a cyclo alkyl group optionally substituted by one or more groups independently selected from alkyl, aryl, halo, alkoxy, amine, phosphine and ether groups; an aryl group optionally substituted by one or more groups independently selected from alkyl, aryl, halo, alkoxy, amine, phosphine and ether groups; with the proviso that when m is 1, one of n, p, q and r is 1 the remaining three being zero, X is O, Y is P, R?1 and R2¿ are both H, R?3 to R11¿ if present are H, and R?12 and R13¿ are both phenyl, then R is not CH¿3?, C(CH3)3, CHPh2, CPh3, adamantyl, C6H3(t-Bu)2, ferrocenyl, CF3, Ph, C6H4OMe, C6H4Me, C6H4NO2 or C6F5, a process for the preparation thereof, metal complexes containing such ligands and the use of such complexes, or combinations of ligand with metal salts or complexes, as catalysts for asymmetric syntheses.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫